CV Tri Murti Andayani

You might also like

Download as docx, pdf, or txt
Download as docx, pdf, or txt
You are on page 1of 7

CURICULUM VITAE

IDENTITAS DIRI

Nama lengkap

: Tri Murti Andayani, Sp FRS., PhD., Apt

Jenis kelamin

: Perempuan

Tempat/tgl lahir

: Kulon Progo, 24-2-1969

Agama

: Islam

Alamat

: Prujakan, Gg. Sirsat 4A, Sinduharjo Ngaglik Sleman

HP

: 08122714562

E-mail

: trimurtia@yahoo.com

Pekerjaan

: Staf Pengajar Fakultas Farmasi UGM

Alamat kantor

: Fakultas Farmasi Universitas Gadjah Mada


Laboratorium Farmakoterapi dan Farmasi Klinik
Jl. Sekip Utara Yogyakarta 55281

NIP

: 196902241997022001

Pangkat/golongan

: Pembina / IV a

Jabatan

: Lektor Kepala

RIWAYAT PENDIDIKAN :
1. Sekolah Dasar

: SDN Wonosari V di Gunungkidul (1975-1981)

2. Sekolah Menengah Pertama

: SMPN 8 Yogyakarta (1981-1984)

3. Sekolah Menengah Atas

: SMAN 3 Yogyakarta (1984-1987)

4. Perguruan Tinggi

a. S-1 Fakultas Farmasi UGM Yogyakarta (1987-1992)


b. Profesi Apoteker Fakultas Farmasi UGM, Yogyakarta (1992-1993)
c. Spesialis-1 Farmasi Rumah Sakit, Fakultas Farmasi Unair Surabaya (1998-2002)
d. S-3, Universiti Sains Malaysia (2007-2011)

RIWAYAT PEKERJAAN :
1. Manajer Penunjang Medik di RS Nirmala Suri Sukoharjo (1993-1997)
2. Apoteker di RS Mata Dr Yap (1997-1998)
3. Apoteker Pengelola Apotek di Apotek Permata Yogyakarta (2003-2004)
4. Staf Pengajar di Fakultas Farmasi UGM (1997 sampai sekarang)

Pengalaman Kerja dalam Penelitian :

PUBLIKASI/ JOURNAL :
1. Andayani TM, Ibrahim MIM, Asdie AH. (2010). The Safety of Triple Therapy with Oral
Antidiabetics versus Insulin in Type 2 diabetes. Asian Journal of Pharmaceutical and
Clinical Research. 3(3).
2. Andayani TM, Ibrahim MIM, Asdie AH. (2010). Comparison of the glycemic control of
insulin and triple oral therapy in type 2 diabetes mellitus. Journal of Diabetes and
Endocrinology. 1(2)

3. Andayani TM, Ibrahim MIM, Asdie AH. (2010). Assessing the Impact of Complications
on The Direct Medical Costs of Type 2 Diabetes Mellitus Outpatients. International
Journal of Current Pharmaceutical Research. 2(2)
4. Andayani TM, Ibrahim MIM, Asdie AH. (2010). The Association of DiabetesRelated
Factor and Quality of Life in Type 2 Diabetes Mellitus. International Journal of
Pharmacy and Pharmaceutical Sciences. 2(1) (Jan-March 2010)
5. Andayani TM, Ibrahim MIM, Asdie AH. (2009). The Effect of Combination Therapy of
Sulfonylurea, Metformin, and Acarbose in Type 2 Diabetes Mellitus Patients with Poorly
Controlled Glycemia. Indonesian Journal of Pharmacy. 20(4):224-230
6. Andayani TM, Ibrahim MIM, Asdie AH. Quality of Life Following a Change in Therapy
to Insulin for Type 2 Diabetes Mellitus Outpatients (letter to editor). (2009). Journal of
Pharmacy Practice and Research . 39(3):249-250, September 2009
7. Andayani TM, Ibrahim MIM, Asdie AH. (2009). Health-Related Quality of Life in Type
2 Diabetes Outpatients in Dr Sardjito Yogyakarta Hospital. Malaysian Journal of
Pharmacy. 1 Issue 7 June 2009
8. Andayani TM. (2006). Cost Analysis of Type 2 Diabetes Mellitus Treatment in Dr
Sardjito Hospital, Yogyakarta. Indonesian Journal of Pharmacist. (17):3
9. Andayani TM. (2005). Economic Evaluation of Antibiotics in the Treatment of
Caesarean Section in PKU Muhammadiyah Yogyakarta. Indonesian Journal of
Pharmacist. (16):2.

SEMINARS
1. Comparison of Effectiveness and Safety Measures of Insulin and Triple Oral Therapy In
Type 2 Diabetes Mellitus. The 23rd Federation of Asian Pharmaceutical Association
Congress (FAPA 2010), Taiwan 5-8 November 2010
2. Assessing the Impact of Complications on the Direct Medical Costs of Type 2 Diabetes
Mellitus Outpatients. The International Conference on Pharmacy and Advanced
Pharmaceutical sciences (oral presentation), Faculty of Pharmacy UGM Yogyakarta
Indonesia, October 2009

3. The Association Between Diabetes Mellitus Medical Cost and Glycemic Control. The
International Conference on Pharmacy and Advanced Pharmaceutical sciences (Poster),
Faculty of Pharmacy UGM Yogyakarta Indonesia, October 2009
4. Quality of Life Following a Change in Therapy to Insulin for Type 2 Diabetes Mellitus
Outpatients. Diabetes Asia 2009 Conference (oral presentation), Kuala Lumpur,
Malaysia, 7-11th October 2009
5. The Association of Diabetes-Related Factor and Quality of Life in Type 2 Diabetes
Mellitus. The 9th Asean Conference on Clinical Pharmacy (oral presentation), Coex,
Seoul, Korea, 26-28th September 2009
6. Combination of Insulin and Acarbose in the Treatment of Type 2 Diabetes . The 9th
Asian Conference on Clinical Pharmacy (Poster), Coex, Seoul, Korea, 26-28th September
2009
7. Health-Related Quality of Life in Type 2 Diabetes Mellitus Outpatients in Dr Sardjito
Yogyakarta Hospital . 4th ASIAN Association of Schools of Pharmacy-9th Malaysian
Pharmaceutical Society Pharmacy Scientific Conference 2009 (oral presentation),
Vistana Hotel, Penang, Malaysia, 10-13th June 2009
8. The Safety of Triple Therapy with Oral Antidiabetics Versus Insulin in Type 2 Diabetes
Mellitus. Second Collaborative Conference, Life Science : Synergy For Enhancement of
Quality of life (Oral Presentation), Universitas Airlangga, Surabaya, Indonesia, 10-11th
February 2009
9. Cost Analysis of Antidiabetic Drugs for Diabetes Mellitus Outpatient in Kodya
Yogyakarta Indonesia Hospital, The 5th Asian Conference on Clinical Pharmacy (oral
presentation), Penang, Malaysia, 2005

Peran Tri Murti Andayani dalam bidang Framakoekonomi dapat dilihat dari pengabdian
beliau sebagai pengajar dan peneliti. Aktif mengikuti seminar, melakukan penelitian dan
mengarang buku mengenai ilmu farmakoekonomi. Berikut kontribusi yang telah diberikan:
1. Bekerja sebagai salah satu dosen UGM bidang Famasi Klinik-Farmakoekonomi yang banyak
melakukan penellitian di bidang farmakoekonomi.
2. Seminar Nasional PERAN APOTEKER DALAM ASPEK MANAJERIAL DAN KLINIS
26 November 2011 di Setia Budi. Tri Murti Andayani, Sp.FRS., Ph.D., Apt. dari UGM
selaku pemateri ke 2 Tri yang menyampaikan materi tentang Penerapan Farmakoekonomi
Allergy In Dermatology.
3. Workshop Farmakoekonomi dan Bussiness Plan, 88 Maret 2014. Selaku pembicara
menegenai konsep farmakoekonomi dalam pemilihan perbekalan farmasi (terutama obat)
secara rasional dan cost-effective.
4. Buku Farmakoekonomi Prinsip dan Metodologi, 2013. Penerbit UD. ADIPURA:
Yogyakarta.
5. Efektivitas-Biaya Penggunaan ACE-inhibitor vs Calcium channel blocker pada Pasien
Hipertensi dengan Diabetes melitus, Jurnal Farmasi Indonesia, vol. -, 2008
6. Efektivitas-biaya dan Monitoring Penggunaan ACE-inhibitor pada Pasien Hipertensi Rawat
jalan, Risalah Temu Ilmiah Nasional II Bidang Farmakologi & Farmasi Klinik , -, -, January
1st 2007
7. Cost-Identification of Diabetes Mellitus Treatment in Dr. Sardjito Hospital Yogyakarta, The
6th ACCP, Thailand, -, Thailand, January 1st 2006
8. Analisis Biaya Terapi Diabetes Melitus di RS Dr Sardjito Yogyakarta, Majalah Farmasi
Indonesia , vol. -, 2006
9. Cost Analysis of Antidiabetic Drugs for Diabetes Mellitus Outpatient in Kodya Yogyakarta
Indonesia Hospital, The 5th ACCP, Penang, -, Penang, January 1st 2005
10. Evaluasi dan Analisis Farmakoekonomi Penggunaan Antibiotika pada Pasien Bedah Sesar
pada suatu Rumah Sakit Swasta (rs x) di Yogyakarta, Kongres Ilmiah XIV ISFI, ISFI, -,
January 1st 2005
11. Analisis Biaya Penggunaan Antihipertensi pada Pasien Rawat Inap di RS PKU
Muhammadiyah Yogyakarta, Kongres HISFARSI, Jakarta, -, Jakarta, January 1st 2005

12. Evaluasi Ekonomi penggunaan Antibiotika pada Kasus Bedah Sesar di RS PKU
Muhammadiyah Yogyakarta, Majalah Farmasi Indonesia , vol. -, 2005
13. Evaluasi Penggunaan Obat Antihipertensi di Rumah Sakit tipe C Yogyakarta, Risalah Temu
Ilmiah Nasional I Bidang Farmakologi & Farmasi Klinik, -, -, January 1st 2004
14. Analisis efektivitas biaya sefalosporin vs amoksisilin pada appendicitis, KONAS IKAFI , -, , January 1st 2004
15. Analisis cost-minimization penggunaan antibiotika sulbenisilin vs koamoksiklav Injeksi
pada bedah sesar, Majalah Farmasi Indonesia, vol. -, 2004
16. Kontrol glikemia pada pasien diabetes melitus tipe 2 rawat jalan dengan terapi insulin di
RSUP Dr Sardjito Yogyakarta, Kongres Ilmiah XVI ISFI, ISFI, -, January 1st 2008
17. The combined effect of triple therapy with sulfonylurea, metformin, and acarbose in type 2
diabetic patients, The 8th ACCP, -, -, January 1st 2008
18. Kualitas Hidup Pasien Diabetes Melitus Tipe 2 Rawat Jalan,Seminar Nasional Hasil
Penelitian antar Klaster, -, UGM, January 1st 200
19. Kualitas Hidup Pasien Geriatri Dengan Multipatologik Di Poliklinik Geriatri Rsup Dr.
Sardjito Yogyakarta Periode November Desember 2007.
20. Pola Penggunaan Dan Analisis Biaya Antibiotika Pada Penyakit Infeksi Saluran Kemih
Pasien Rawat Inap Di Rumah Sakit Pku Muhammadiyah Yogyakarta Periode Januari-Juni
2007

You might also like